(Q51371881)

4 April 2018

title

Osteoid osteoma is an osteocalcinoma affecting glucose metabolism. (English)

1 reference

4 April 2018

1 reference

C B Confavreux

1

1 reference

4 April 2018

O Borel

2

1 reference

4 April 2018

F Lee

3

1 reference

4 April 2018

G Vaz

4

1 reference

4 April 2018

M Guyard

5

1 reference

4 April 2018

C Fadat

6

1 reference

4 April 2018

M-C Carlier

7

1 reference

4 April 2018

R Chapurlat

8

1 reference

4 April 2018

G Karsenty

9

1 reference

4 April 2018

language of work or name

English

0 references

publication date

17 June 2011

1 reference

4 April 2018

Osteoporosis International

published in

1 reference

4 April 2018

volume

23

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

1645-1650

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00198-011-1684-0

exact match

0 references

cites work

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Convergence between bone and energy homeostases: leptin regulation of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Bone: from a reservoir of minerals to a regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Salsalate improves glycemia and inflammatory parameters in obese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Association between serum osteocalcin and markers of metabolic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1684-0

Evaluation of glucose homeostasis

21 January 2018

1 reference

12 December 2020

Effects of nonsteroidal antiinflammatory drugs in conventional dosage on glucose homeostasis in patients with diabetes.

1 reference

12 December 2020

The association between serum osteocalcin levels and metabolic syndrome in Koreans

1 reference

12 December 2020

Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study

1 reference

12 December 2020

10.1007/S00198-011-1684-0

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018